KLRK1 and malignant colon neoplasm: In line with this, other studies involving patients with progressive breast, lung, ovarian, or colon cancer have shown sMIC-induced downregulation of surface NKG2D expression on NK cells and/or cytotoxic T cells as a possible mechanism of tumor immune evasion [20], [37].